p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN

Cell Death and Differentiation

Volumn 21, Issue 1, 2014, Pages 146-160

  Hong, S W ^a   Moon, J H ^a   Kim, J S ^a   Shin, J S ^a   Jung, K A ^a   Lee, W K ^b   Jeong, S Y ^a   Hwang, J J ^a   Lee, S J ^a,c   Suh, Y A ^a   Kim, I ^a   Nam, K Y ^c   Han, S ^a   Kim, J E ^a   Kim, K P ^a   Hong, Y S ^a   Lee, J L ^a   Lee, W J ^d   Choi, E K ^a   Lee, J S ^a   Jin, D H ^a   Kim, T W ^a   more..

^a University of Ulsan College of Medicine   (South Korea)

^b Myong Ji University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

NEDD4 1; p34; PTEN; ubiquitination

Indexed keywords

BINDING PROTEIN; NEDD4 1 PROTEIN; P34 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CARCINOGENICITY; CELL PROLIFERATION; GENE SILENCING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; UBIQUITINATION;

CELL LINE, TUMOR; CELL PROLIFERATION; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; HEK293 CELLS; HUMANS; MCF-7 CELLS; NUCLEAR PROTEINS; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; PTEN PHOSPHOHYDROLASE; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84890123495     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.141     Document Type: Article

References (33)

1. Tamura M, Gu J, Tran H, Yamada KM. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 1999; 91: 1820-1828.
2. Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009; 4: 127-150.
3. Blanco-Aparicio C, Renner O, Leal JF, Carnero A. PTEN, more than the AKT pathway. Carcinogenesis 2007; 28: 1379-1386.
4. Furnari FB, Lin H, Huang HS, Cavenee WK. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 1997; 94: 12479-12484.
5. Tamguney T, Stokoe D. New insights into PTEN. J Cell Sci 2007; 120(Pt 23): 4071-4079.
6. Planchon SM, Waite KA, Eng C. The nuclear affairs of PTEN. J Cell Sci 2008; 121(Pt 3): 249-253.
7. Baker SJ. PTEN enters the nuclear age. Cell 2007; 128: 25-28.
8. Song MS, Carracedo A, Salmena L, Song SJ, Egia A, Malumbres M et al. Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 2011; 144: 187-199.
9. Fata JE, Debnath S, Jenkins EC Jr, Fournier MV. Nongenomic mechanisms of PTEN Regulation. Int J Cell Biol 2012; 2012: 379685.
10. Singh G, Chan AM. Post-Translational modifications of PTEN and their potential therapeutic implications. Curr Cancer Drug Targets 2011; 11: 536-547.
11. Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007; 128: 141-156.
12. Wang X, Shi Y, Wang J, Huang G, Jiang X. Crucial role of the C-Terminus of PTEN in antagonizing NEDD4-1-mediated PTEN ubiquitination and degradation. Biochem J 2008; 414: 221-229.
13. Zhang S, Yu D. PI(3)king apart PTEN's role in cancer. Clin Cancer Res 2010; 16: 4325-4330.
14. Fouladkou F, Landry T, Kawabe H, Neeb A, Lu C, Brose N et al. The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc Natl Acad Sci USA 2008; 105: 8585-8590.
15. Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13: 283-296.
16. Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 2007; 128: 129-139.
17. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436: 725-730.
18. Huang Q, Szebenyi DM. Structural basis for the interaction between the growth factor-binding protein GRB10 and the E3 ubiquitin ligase NEDD4. J Biol Chem 2010; 285: 42130-42139.
19. Van Themsche C, Leblanc V, Parent S, Asselin E. X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization. J Biol Chem 2009; 284: 20462-20466.
20. Hsu SI, Yang CM, Sim KG, Hentschel DM, O'Leary E, Bonventre JV. TRIP-Br: A novel family of PHD zinc finger- And bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1. EMBO J 2001; 20: 2273-2285.
21. Sugimoto M, Nakamura T, Ohtani N, Hampson L, Hampson IN, Shimamoto A et al. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1). Genes Dev 1999; 13: 3027-3033.
22. Hoglund M, Gorunova L, Andren-Sandberg A, Dawiskiba S, Mitelman F, Johansson B. Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: Frequent loss of 19p13.3 and gain of 19q13.1-13.2. Genes Chromosomes Cancer 1998; 21: 8-16.
23. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schrock E, du Manoir S et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 1994; 54: 1801-1806.
24. Tang TC, Sham JS, Xie D, Fang Y, Huo KK, Wu QL et al. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines. Cancer Res 2002; 62: 7157-7161.
25. Hong SW, Kim CJ, Park WS, Shin JS, Lee SD, Ko SG et al. p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: P34SEI-1 as a novel target for anti-breast cancer strategies. Cancer Res 2009; 69: 741-746.
26. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y et al. Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association. Cell 1999; 99: 323-334.
27. Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 2003; 13: 49-58.
28. Li Y, Pei J, Xia H, Ke H, Wang H, Tao W. Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 2003; 22: 4398-4405.
29. Chen R, Li L, Weng Z. ZDOCK: An initial-stage protein-docking algorithm. Proteins 2003; 52: 80-87.
30. Li L, Chen R, Weng Z. RDOCK: Refinement of rigid-body protein docking predictions. Proteins 2003; 53: 693-707.
31. Zhang C, Vasmatzis G, Cornette JL, DeLisi C. Determination of atomic desolvation energies from the structures of crystallized proteins. J Mol Biol 1997; 267: 707-726.
32. Brooks BR, Brooks CL 3rd, Mackerell AD Jr, Nilsson L, Petrella RJ, Roux B et al. CHARMM: The biomolecular simulation program. J Comput Chem 2009; 30: 1545-1614.
33. Chen R, Weng Z. A novel shape complementarity scoring function for protein-protein docking. Proteins 2003; 51: 397-408.